Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Clin Cancer Res. 2010 Sep 13;16(21):5222–5232. doi: 10.1158/1078-0432.CCR-10-1282

Figure 1.

Figure 1

Kaplan-Meier survival analysis of intrinsic subtype (panels A and B) and Risk of Relapse score (ROR-S, panels C and D), as determined by PAM50 gene expression measurement by qRT-PCR performed on paraffin blocks from women with invasive breast carcinoma, treated with adjuvant tamoxifen. The number of events and total number of patients in each group is shown beside each curve’s description. RFS = relapse-free survival (panels A and C). DSS = breast cancer disease-specific survival (panels B and D; excludes two cases with unknown cause of death).